Showing results (271-280 of 317) with videos related to
Sort By:
Pageof 32
La Clinica Terapeutica|August 25, 2000
Emerging role of protectin (CD59) in humoral immunotherapy of solid malignanciesE Fonsatti, M Altomonte, S Coral, et al.Cancer Research|June 1, 1989
Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potentialM Maio, B Gulwani, J A Langer, et al.Cancer Immunology, Immunotherapy : CII|July 22, 1999
In vitro analysis of the melanoma/endothelium interaction increasing the release of soluble intercellular adhesion molecule 1 by endothelial cellsE Fonsatti, E Lamaj, S Coral, et al.International Journal of Oncology|July 17, 1998
Structure, distribution, and functional role of protectin (CD59) in complement-susceptibility and in immunotherapy of human malignancies (Review)M Maio, L I Brasoveanu, S Coral, et al.Journal of Cellular Physiology|May 31, 2001
Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignanciesE Fonsatti, L Del Vecchio, M Altomonte, et al.Molecular Immunology|March 1, 1993
Insertion of constant region domains of human IgG1 into CD4-PE40 increases its plasma half-lifeJ K Batra, S Kasturi, M G Gallo, et al.Journal of Experimental & Clinical Cancer Research : CR|June 7, 2007
Primary hepatic epithelioid hemangioendothelioma progressively responsive to interferon-alpha: is there room for novel anti-angiogenetic treatments?L Calabrò, A M Di Giacomo, M Altomonte, et al.Cancer Gene Therapy|January 23, 1999
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectorsM Di Nicola, S Siena, M Bregni, et al.British Journal of Cancer|September 15, 2001
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutationG Della Torre, B Pasini, S Frigerio, et al.Cell Host & Microbe|October 22, 2013
HIV-1 Vif adaptation to human APOBEC3H haplotypesMarcel Ooms, Bonnie Brayton, Michael Letko, et al.Pageof 32